iShares MBS ETF vs Personalis Inc. Common Stock — how do they compare? iShares MBS ETF trades at $89.99 (market cap $35.76B), while Personalis Inc. Common Stock trades at $16.14 (market cap $1.70B). The key difference: iShares MBS ETF is far larger — about 21× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MBS ETF for 97 Days and Personalis Inc. Common Stock for 0 Days on average.
| MBB | PSNL | |
|---|---|---|
Market Cap | $35.76B | $1.70B |
Volume | 19,694,940 | 3,262,398 |
Sector | Fixed Income | Health |
52-Week High | $96.91 | $18.38 |
52-Week Low | $89.09 | $5.04 |
Typical Hold Time | 97 Days | 0 Days |
Enterprise Value | — | $1.52B |
Signals from Pluang's Aura AI — not financial advice
MBB trades at $90.00 with minimal daily movement (+0.19%). Technical indicators signal bearish momentum with RSI at overbought levels and moving averages trending downward. Recent news highlights significant short interest growth (98.3% increase in September 2026) and concerns about intermediate duration risk amid potential rate hikes. The ETF faces pressure from rising rates while maintaining consistent dividend distributions.
The outlook remains cautious given the bearish technical setup and interest rate sensitivity. While institutional buying provides some support, the combination of high short interest and duration risk creates headwinds. Investors should weigh the steady income against potential price depreciation in a rising rate environment.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →